- Home
- TEVA
as 01-21-2025 4:00pm EST
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
| Founded: | 1901 | Country: | Israel |
| Employees: | N/A | City: | TEL AVIV |
| Market Cap: | 23.7B | IPO Year: | N/A |
| Target Price: | $22.43 | AVG Volume (30 days): | 8.9M |
| Analyst Decision: | Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.86 | EPS Growth: | N/A |
| 52 Week Low/High: | $11.48 - $22.80 | Next Earning Date: | 01-29-2025 |
| Revenue: | $16,772,000,000 | Revenue Growth: | 9.81% |
| Revenue Growth (this year): | 5.74% | Revenue Growth (next year): | 4.46% |
Latest Teva Pharmaceutical Industries Limited News
TEVA Breaking Stock News: Dive into TEVA Ticker-Specific Updates for Smart Investing
TipRanks
4 days ago
Ozempic, Xtandi among next 15 drugs selected for U.S. price talks
MT Newswires
4 days ago
Update: Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks
Yahoo Finance
5 days ago
Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations
Yahoo Finance Video
8 days ago
How Teva Pharmaceuticals is thinking about Trump's return: CEO
Zacks
8 days ago
Amicus Posts Preliminary 2024 Results, Issues 2025 Outlook
MT Newswires
9 days ago
Teva Pharmaceuticals International Enters Collaboration to Commercialize Eye Disease Treatment
GlobeNewswire
9 days ago
Teva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel
MT Newswires
12 days ago
Teva Pharmaceutical, Samsung Bioepis to Commercialize Epysqli in US
Compare TEVA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TEVA Teva Pharmaceutical Industries Limited - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.